As of Jul 26, 2024, the Dexcom stock's P/E ratio is 38.79. This takes into account the latest EPS of $1.65 and stock price of $64. The PE ratio has decreased by 62% from its last 4 quarters average of 101.5.
The PE ratio of Dexcom has averaged 139.14 over the last six years. The current price-to-earnings ratio of 38.79 is 72% less than the historical average. Analyzing the last six years, DXCM's PE ratio reached its highest point in the Sep 2018 quarter at 298, when the price was $35.76 and the EPS was $0.12. The lowest point was recorded in the Mar 2021 quarter, when it reached 57.97 with a price of $89.85 and an EPS of $1.55.
Maximum annual increase: 278.63% in 2021
Maximum annual decrease: -67.58% in 2020
| Year | PE ratio | Change |
|---|---|---|
| 2023 | 88.64 | -31.12% |
| 2022 | 128.68 | -46.32% |
| 2021 | 239.71 | 278.63% |
| 2020 | 63.31 | -67.58% |
| 2019 | 195.3 | N/A |
| 2018 | N/A | N/A |
| 2017 | N/A | N/A |
| 2016 | N/A | N/A |
| 2015 | N/A | N/A |
| 2014 | N/A | N/A |
DXCM's current PE ratio is under its 3, 5 and 10-year averages.
DXCM's PE ratio is less than its peer stocks BDX and WST, but it is above JNJ's and ABT's. Dexcom's current PE ratio of 38.79 is more than the average of its peers, which is 31.77.
| Stock name | PE ratio | Market cap |
|---|---|---|
| JNJ Johnson & Johnson | 10.55 | $386.7B |
| EW Edwards Lifesciences Corp | 26.77 | $37.55B |
| MDT Medtronic plc | 28.41 | $100.91B |
| ABT Abbott Laboratories | 32.58 | $183.08B |
| DXCM Dexcom Inc | 38.79 | $25.45B |
| WST West Pharmaceutical Services Inc | 40.05 | $20.66B |
| BDX Becton Dickinson & Co | 52.27 | $68.58B |
| TNDM Tandem Diabetes Care Inc | N/A | $2.59B |
| QDEL Quidel Corp | N/A | $2.61B |
The price to earnings ratio for DXCM stock is 38.79 as of Jul 26, 2024.
As an average over the last 3 years, DXCM stock has a PE ratio of 132.02.
As an average over the last 5 years, DXCM stock has a PE ratio of 130.31.
Over the last six years, the quarterly PE ratio reached its highest level at 298 in the Sep 2018 quarter.
DXCM's price to earnings ratio is currently 72% below its 6-year historical average.
The P/E ratio is calculated by dividing the latest price of a stock by its trailing twelve months EPS. As of today (Jul 26, 2024), Dexcom's share price is $64. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2024 is $1.65. Therefore, Dexcom's price to earnings ratio for today is 38.79. PE RATIO(38.79) = STOCK PRICE($64) / TTM EPS($1.65)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.